GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » Other Current Assets

EZZ Life Science Holdings (ASX:EZZ) Other Current Assets : A$2.14 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings Other Current Assets?

EZZ Life Science Holdings's other current assets for the quarter that ended in Dec. 2023 was A$2.14 Mil.

EZZ Life Science Holdings's quarterly other current assets declined from Dec. 2022 (A$1.19 Mil) to Jun. 2023 (A$0.94 Mil) but then increased from Jun. 2023 (A$0.94 Mil) to Dec. 2023 (A$2.14Mil).

EZZ Life Science Holdings's annual other current assets increased from Jun. 2021 (A$0.42 Mil) to Jun. 2022 (A$0.90 Mil) increased from Jun. 2022 (A$0.90 Mil) to Jun. 2023 (A$0.94 Mil).


EZZ Life Science Holdings Other Current Assets Historical Data

The historical data trend for EZZ Life Science Holdings's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings Other Current Assets Chart

EZZ Life Science Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Other Current Assets
0.34 0.42 0.90 0.94

EZZ Life Science Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Assets Get a 7-Day Free Trial 0.51 0.90 1.19 0.94 2.14

EZZ Life Science Holdings Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.


EZZ Life Science Holdings Other Current Assets Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's Other Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


EZZ Life Science Holdings (ASX:EZZ) Business Description

Traded in Other Exchanges
N/A
Address
104 Derby Street, Silverwater, NSW, AUS, 2128
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines